NM highlights. Immigration detention centers. US outbreak perceptions. States lockdown protests. Drones sample transport. Black market antivirals. NZ eases lockdown. Germany partial reopening. Low temperature/humidity favors transmission. Wastewater epidemiology. Contact tracing privacy. D-dimer severity prediction. China fatality factors. Group testing. High throughput testing. Pet testing. WHO misinformation countermeasure. WHO produce washing. Public health strategies. Fellows education adaptations. Mental health priorities. Practice guidelines: immunocompromised cancer patients, IBD, tracheostomy, trauma surgery, neurovascular management, head & neck cancer surgery, long-term care, and respiratory home care. Remdesivir macaque clinical benefit. Hydroxychloroquine meta-analysis. Heparin anticoagulant therapy. Hypothiocyanite hypothesis. 36 new clinical trials. Neutrophil lymphocyte ratio. Blood coagulation. Viral organ system reach. Optimal antiviral dosing.
Lambert, Christophe G.; Shawn Stoicu; Ingrid Hendrix; Lori Sloane; Anastasiya Nestsiarovich; Praveen Kumar; Nicolas Lauve; Hannah Groves; Rachel D. King; Estefania Montanez; Malik Alqawasmi; Samuel Anyona; Evans Raballah; Elly Munde; Cristian Bologa; Alexandra Yinglng; Gregory Mertz; Kristine Tollestrup; Orrin Myers; and Douglas J. Perkins. "2020-04-20 DAILY UNM GLOBAL HEALTH COVID-19 BRIEFING." (2020). https://digitalrepository.unm.edu/hsc_covid19_briefings/17